Clinical trials

Clinical trials are essential to determine whether new drugs or diagnostics are safe and effective when used to diagnose or treat people. Interested in learning about or participating in one of our clinical trials?

Visit our ForPatients platform

How clinical trials work

Serendipity put Larry Tsai in the right place at the right time

About a year ago, Larry Tsai became Global Head of Respiratory and Rheumatology Product Development at Roche. Some six months later, the pandemic arrived.

A clinical study of pandemic proportions

Setting up robust clinical trials can take six months or even a year. A Roche team did it in 15 days during the pandemic.

Clinical trials 101

A Roche biostatistician explains what happens in rigorous clinical trials, and why not all studies provide the same quality of information.

What is a clinical trial and how does it work?

Every new treatment is usually tested in three phases of clinical trials before regulatory agencies consider it safe and effective.

Ever wondered how patient outcomes are measured in clinical trials?

Today, approaches that measure cancer treatment are more comprehensive – they look to extend patients’ lives and maintain quality of life.

Following global standards

All Roche clinical studies, no matter where they are conducted, are managed in compliance with international guidelines.

Protecting Patient Safety

Patient safety is a top priority. Find out how we optimise patient safety throughout the lifecycle of a medicine.

ForPatients

Developed in partnership with patients, ForPatients aims to support patients on their journey.

Pipeline

Get up-to-date information about our Pharma and Diagnostics pipeline.

Access to investigational medicines outside of a clinical trial

Some patients with serious or immediately life-threatening diseases may not be eligible for any clinical trials and may not have other options. Under specific circumstances and in compliance with applicable laws, we may provide patients with pre-approval access (PAA) to unapproved or investigational medicines outside the clinical trials process, before they are approved by regulatory authorities.

Tags: Patients